AccessPak for HIV PEP Expanded with Kaletra and Letrozole and ribociclib
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Letrozole and ribociclib and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Leucovorin
- AccessPak for HIV PEP Expanded with Kaletra-Leucovorin Calcium
- AccessPak for HIV PEP Expanded with Kaletra-Leucovorin injection
- AccessPak for HIV PEP Expanded with Kaletra-Leucovorin Oral, Intravenous, Injection
- AccessPak for HIV PEP Expanded with Kaletra-Leucovorin Tablets
- AccessPak for HIV PEP Expanded with Kaletra-Leukeran
- Letrozole and ribociclib-AccessPak for HIV PEP Expanded with Viracept
- Letrozole and ribociclib-Accolate
- Letrozole and ribociclib-Accretropin
- Letrozole and ribociclib-Accucaine
- Letrozole and ribociclib-AccuHist Drops
- Letrozole and ribociclib-AccuHist PDX Drops